학술논문

Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma.
Document Type
Article
Source
Nature Communications; 10/27/2022, Vol. 13 Issue 1, p1-18, 18p
Subject
IMMUNE checkpoint proteins
PANCREATIC duct
VASOACTIVE intestinal peptide
T cells
IMMUNE response
T cell receptors
IMMUNOGLOBULINS
Language
ISSN
20411723
Abstract
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)